| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.743 | 0.019 | 0.809 | Caspase 9 stimulant | 0.809 0.01 CID_154699930 | CID_154699930 | |
| 0.646 | 0.004 | 0.646 | GABA C receptor rho-3 antagonist | 0.566 0.012 CID_154699930 | ||
| 0.632 | 0.015 | 0.632 | Aldehyde oxidase inhibitor | 0.372 0.051 CID_154699930 | ||
| 0.595 | 0.012 | 0.595 | 5 Hydroxytryptamine release inhibitor | 0.594 0.012 CID_154699930 | ||
| 0.582 | 0.004 | 0.582 | DNA intercalator | 0.511 0.005 CID_154699930 | ||
| 0.557 | 0.014 | 0.557 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.426 0.079 CID_154699930 | ||
| 0.552 | 0.02 | 0.552 | 5 Hydroxytryptamine release stimulant | 0.439 0.038 CID_154699930 | ||
| 0.546 | 0.017 | 0.675 | Histamine release inhibitor | 0.675 0.005 CID_154699930 | CID_154699930 | |
| 0.496 | 0.01 | 0.496 | Peroxidase inhibitor | 0.36 0.027 CID_154699930 | ||
| 0.491 | 0.005 | 0.491 | NOS3 expression enhancer | 0.385 0.009 CID_154699930 | ||
| 0.504 | 0.023 | 0.633 | Aryl hydrocarbon receptor agonist | 0.633 0.013 CID_154699930 | CID_154699930 | |
| 0.525 | 0.067 | 0.634 | Apoptosis agonist | 0.634 0.042 CID_154699930 | CID_154699930 | |
| 0.448 | 0.007 | 0.448 | Alpha-N-acetylglucosaminidase inhibitor | 0.213 0.03 CID_154699930 | ||
| 0.45 | 0.01 | 0.45 | Death-associated protein kinase 3 inhibitor | |||
| 0.477 | 0.037 | 0.477 | Calcium channel L-type activator | 0.253 0.202 CID_154699930 | ||
| 0.447 | 0.012 | 0.447 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.426 | 0.006 | 0.426 | Tyrosine 3 hydroxylase inhibitor | 0.305 0.031 CID_154699930 | ||
| 0.43 | 0.012 | 0.43 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.437 | 0.021 | 0.437 | Superoxide dismutase inhibitor | 0.318 0.044 CID_154699930 | ||
| 0.421 | 0.011 | 0.421 | 5 Hydroxytryptamine uptake stimulant | 0.278 0.058 CID_154699930 | ||
| 0.44 | 0.032 | 0.672 | Caspase 3 stimulant | 0.672 0.007 CID_154699930 | CID_154699930 | |
| 0.414 | 0.02 | 0.414 | Calcium channel activator | 0.293 0.098 CID_154699930 | ||
| 0.399 | 0.014 | 0.399 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.383 | 0.005 | 0.383 | Telomerase inhibitor | 0.303 0.006 CID_154699930 | ||
| 0.375 | 0.002 | 0.375 | MAP3K9 inhibitor | 0.286 0.004 CID_154699930 | ||
| 0.383 | 0.012 | 0.383 | Protein kinase C nu inhibitor | |||
| 0.39 | 0.028 | 0.463 | Dyrk kinase inhibitor | 0.463 0.017 CID_154699930 | CID_154699930 | |
| 0.386 | 0.028 | 0.485 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.485 0.014 CID_154699930 | CID_154699930 | |
| 0.363 | 0.006 | 0.363 | Cystathionine beta-synthase inhibitor | 0.278 0.012 CID_154699930 | ||
| 0.388 | 0.031 | 0.451 | DNA damaging | 0.451 0.019 CID_154699930 | CID_154699930 | |
| 0.362 | 0.006 | 0.362 | GABA C receptor agonist | 0.16 0.03 CID_154699930 | ||
| 0.37 | 0.021 | 0.37 | Cyclic AMP phosphodiesterase inhibitor | 0.267 0.056 CID_154699930 | ||
| 0.348 | 0.009 | 0.377 | Neurotrophic factor enhancer | 0.377 0.007 CID_154699930 | CID_154699930 | |
| 0.333 | 0.004 | 0.333 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.193 0.023 CID_154699930 | ||
| 0.355 | 0.027 | 0.355 | Clk dual-specificity kinase inhibitor | 0.255 0.053 CID_154699930 | ||
| 0.335 | 0.008 | 0.37 | Topoisomerase I inhibitor | 0.37 0.006 CID_154699930 | CID_154699930 | |
| 0.357 | 0.033 | 0.357 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.325 | 0.005 | 0.325 | Ferrochelatase inhibitor | 0.124 0.051 CID_154699930 | ||
| 0.337 | 0.023 | 0.337 | CDC-like kinase 4 inhibitor | 0.172 0.084 CID_154699930 | ||
| 0.33 | 0.016 | 0.33 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.293 0.026 CID_154699930 | ||
| 0.328 | 0.015 | 0.474 | Topoisomerase II inhibitor | 0.474 0.007 CID_154699930 | CID_154699930 | |
| 0.312 | 0.005 | 0.312 | GABA C receptor rho-2 antagonist | 0.233 0.016 CID_154699930 | ||
| 0.349 | 0.045 | 0.385 | Hypoxia-inducible factor 1 alpha inhibitor | 0.385 0.034 CID_154699930 | CID_154699930 | |
| 0.324 | 0.02 | 0.324 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.295 | 0.005 | 0.42 | Estrogen receptor beta antagonist | 0.42 0.004 CID_154699930 | CID_154699930 | |
| 0.286 | 0.004 | 0.286 | Photosensitizer | 0.215 0.01 CID_154699930 | ||
| 0.287 | 0.006 | 0.297 | 5 Hydroxytryptamine 3E antagonist | 0.297 0.005 CID_154699930 | CID_154699930 | |
| 0.351 | 0.073 | 0.351 | Vasodilator, peripheral | 0.225 0.148 CID_154699930 | ||
| 0.299 | 0.027 | 0.299 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.284 | 0.013 | 0.284 | Succinate dehydrogenase inhibitor | 0.243 0.025 CID_154699930 | ||
| 0.301 | 0.031 | 0.301 | RNA-directed DNA polymerase inhibitor | 0.259 0.044 CID_154699930 | ||
| 0.316 | 0.047 | 0.316 | Transcription factor STAT inhibitor | 0.221 0.11 CID_154699930 | ||
| 0.27 | 0.007 | 0.351 | Estrogen antagonist | 0.351 0.005 CID_154699930 | CID_154699930 | |
| 0.272 | 0.009 | 0.272 | ATPase inhibitor | 0.244 0.015 CID_154699930 | ||
| 0.289 | 0.036 | 0.289 | Anesthetic general | 0.163 0.101 CID_154699930 | ||
| 0.296 | 0.045 | 0.296 | DNA synthesis inhibitor | 0.213 0.103 CID_154699930 | ||
| 0.301 | 0.053 | 0.301 | Transcription factor STAT3 inhibitor | 0.207 0.124 CID_154699930 | ||
| 0.302 | 0.057 | 0.302 | Insulysin inhibitor | 0.25 0.097 CID_154699930 | ||
| 0.251 | 0.006 | 0.251 | GABA C receptor antagonist | 0.15 0.03 CID_154699930 | ||
| 0.247 | 0.005 | 0.247 | CYP2A6 inhibitor | 0.237 0.005 CID_154699930 | ||
| 0.252 | 0.01 | 0.327 | Topoisomerase II alpha inhibitor | 0.327 0.006 CID_154699930 | CID_154699930 | |
| 0.32 | 0.079 | 0.32 | Cholesterol antagonist | 0.203 0.162 CID_154699930 | ||
| 0.245 | 0.005 | 0.245 | MAP kinase kinase 4 inhibitor | 0.167 0.036 CID_154699930 | ||
| 0.282 | 0.043 | 0.282 | 5 Hydroxytryptamine 1E antagonist | 0.264 0.059 CID_154699930 | ||
| 0.254 | 0.016 | 0.254 | Hexokinase inhibitor | 0.174 0.054 CID_154699930 | ||
| 0.242 | 0.005 | 0.242 | Phenylalanine 4-hydroxylase inhibitor | 0.099 0.026 CID_154699930 | ||
| 0.282 | 0.047 | 0.282 | Gastrin inhibitor | 0.189 0.165 CID_154699930 | ||
| 0.239 | 0.006 | 0.239 | T cell inhibitor | 0.113 0.017 CID_154699930 | ||
| 0.237 | 0.004 | 0.237 | Glutamate release inhibitor | 0.15 0.01 CID_154699930 | ||
| 0.237 | 0.005 | 0.237 | GABA C receptor rho-1 antagonist | 0.153 0.02 CID_154699930 | ||
| 0.249 | 0.018 | 0.249 | Aldehyde dehydrogenase inhibitor | 0.153 0.045 CID_154699930 | ||
| 0.241 | 0.014 | 0.241 | UDP-glucose 4-epimerase inhibitor | 0.133 0.035 CID_154699930 | ||
| 0.256 | 0.029 | 0.256 | Nitric-oxide synthase stimulant | 0.206 0.079 CID_154699930 | ||
| 0.232 | 0.006 | 0.232 | HIV-1 integrase (Overall Integration) inhibitor | 0.155 0.023 CID_154699930 | ||
| 0.235 | 0.009 | 0.235 | 5 Hydroxytryptamine 7 antagonist | 0.068 0.038 CID_154699930 | ||
| 0.233 | 0.009 | 0.233 | Porphobilinogen synthase inhibitor | 0.083 0.045 CID_154699930 | ||
| 0.238 | 0.014 | 0.238 | Catenin beta inhibitor | |||
| 0.29 | 0.067 | 0.29 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.188 0.108 CID_154699930 | ||
| 0.23 | 0.012 | 0.23 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.044 CID_154699930 | ||
| 0.232 | 0.017 | 0.232 | Mannose-6-phosphate isomerase inhibitor | 0.218 0.022 CID_154699930 | ||
| 0.326 | 0.113 | 0.429 | 15-Lipoxygenase inhibitor | 0.429 0.062 CID_154699930 | CID_154699930 | |
| 0.242 | 0.031 | 0.242 | 3C-like protease (Human coronavirus) inhibitor | 0.235 0.034 CID_154699930 | ||
| 0.254 | 0.044 | 0.254 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.245 | 0.038 | 0.265 | Mcl-1 antagonist | 0.265 0.031 CID_154699930 | CID_154699930 | |
| 0.218 | 0.01 | 0.218 | 5 Hydroxytryptamine 3A agonist | 0.139 0.042 CID_154699930 | ||
| 0.217 | 0.01 | 0.217 | Alcohol dehydrogenase inhibitor | 0.109 0.044 CID_154699930 | ||
| 0.218 | 0.013 | 0.218 | CF transmembrane conductance regulator agonist | 0.146 0.084 CID_154699930 | ||
| 0.256 | 0.051 | 0.256 | MAP kinase kinase 2 inhibitor | 0.158 0.114 CID_154699930 | ||
| 0.23 | 0.025 | 0.23 | Toll-Like receptor 9 antagonist | 0.15 0.063 CID_154699930 | ||
| 0.21 | 0.009 | 0.21 | Creatine kinase inhibitor | 0.15 0.024 CID_154699930 | ||
| 0.223 | 0.022 | 0.223 | DNA polymerase I inhibitor | |||
| 0.297 | 0.096 | 0.377 | Transcription factor NF kappa B inhibitor | 0.377 0.069 CID_154699930 | CID_154699930 | |
| 0.209 | 0.01 | 0.209 | Triose-phosphate isomerase inhibitor | 0.111 0.038 CID_154699930 | ||
| 0.241 | 0.043 | 0.241 | LIM domain kinase 1 inhibitor | 0.133 0.117 CID_154699930 | ||
| 0.24 | 0.043 | 0.24 | Focal adhesion kinase 2 inhibitor | 0.206 0.065 CID_154699930 | ||
| 0.284 | 0.089 | 0.371 | 12-Lipoxygenase inhibitor | 0.371 0.048 CID_154699930 | CID_154699930 | |
| 0.264 | 0.069 | 0.264 | Interleukin agonist | |||
| 0.208 | 0.017 | 0.208 | Nav1.6 sodium channel blocker | 0.14 0.067 CID_154699930 | ||
| 0.198 | 0.007 | 0.198 | Alcohol oxidase inhibitor | 0.061 0.034 CID_154699930 | ||
| 0.199 | 0.009 | 0.199 | Protein kinase C delta inhibitor | |||
| 0.203 | 0.013 | 0.203 | Protein kinase C gamma inhibitor | 0.108 0.064 CID_154699930 | ||
| 0.231 | 0.048 | 0.231 | I kappa B kinase epsilon inhibitor | 0.17 0.099 CID_154699930 | ||
| 0.197 | 0.015 | 0.197 | TIE antagonist | |||
| 0.195 | 0.015 | 0.195 | TIE-2 antagonist | |||
| 0.19 | 0.01 | 0.19 | Prolactin inhibitor | 0.101 0.054 CID_154699930 | ||
| 0.206 | 0.028 | 0.206 | Arachidonic acid antagonist | 0.181 0.052 CID_154699930 | ||
| 0.194 | 0.016 | 0.194 | Adenylate kinase inhibitor | 0.113 0.05 CID_154699930 | ||
| 0.191 | 0.012 | 0.191 | Protein kinase C zeta inhibitor | 0.132 0.026 CID_154699930 | ||
| 0.295 | 0.117 | 0.295 | Calpain 2 inhibitor | 0.208 0.18 CID_154699930 | ||
| 0.189 | 0.012 | 0.189 | Sphingomyelinase inhibitor | 0.144 0.027 CID_154699930 | ||
| 0.21 | 0.033 | 0.21 | Heat shock protein 90 antagonist | 0.191 0.042 CID_154699930 | ||
| 0.191 | 0.015 | 0.191 | Activin receptor-like kinase 4 inhibitor | 0.111 0.066 CID_154699930 | ||
| 0.22 | 0.045 | 0.22 | Histone acetyltransferase inhibitor | 0.174 0.108 CID_154699930 | ||
| 0.19 | 0.016 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.06 CID_154699930 | ||
| 0.279 | 0.106 | 0.295 | Vasodilator, coronary | 0.295 0.092 CID_154699930 | CID_154699930 | |
| 0.18 | 0.007 | 0.18 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 CID_154699930 | ||
| 0.204 | 0.033 | 0.204 | Neurotensin receptor agonist | 0.161 0.078 CID_154699930 | ||
| 0.184 | 0.013 | 0.184 | Sphingosine 1-phosphate receptor 4 antagonist | 0.152 0.031 CID_154699930 | ||
| 0.221 | 0.051 | 0.221 | Growth hormone agonist | |||
| 0.208 | 0.039 | 0.208 | Phospholipase C inhibitor | 0.193 0.049 CID_154699930 | ||
| 0.189 | 0.021 | 0.189 | Nav1.1 sodium channel blocker | |||
| 0.223 | 0.056 | 0.223 | Non-steroidal antiinflammatory agent | 0.148 0.117 CID_154699930 | ||
| 0.187 | 0.02 | 0.187 | Adenylate cyclase stimulant | 0.159 0.049 CID_154699930 | ||
| 0.21 | 0.044 | 0.21 | Heat shock protein 90 alpha antagonist | 0.206 0.046 CID_154699930 | ||
| 0.172 | 0.006 | 0.172 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 CID_154699930 | ||
| 0.257 | 0.095 | 0.312 | Lipoxygenase inhibitor | 0.312 0.065 CID_154699930 | CID_154699930 | |
| 0.219 | 0.057 | 0.219 | CDC-like kinase 2 inhibitor | |||
| 0.174 | 0.013 | 0.174 | NADH dehydrogenase inhibitor | 0.102 0.042 CID_154699930 | ||
| 0.275 | 0.114 | 0.384 | Prostaglandin dehydrogenase inhibitor | 0.384 0.072 CID_154699930 | CID_154699930 | |
| 0.232 | 0.072 | 0.232 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.196 | 0.038 | 0.196 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.111 CID_154699930 | ||
| 0.217 | 0.061 | 0.217 | DNA methyltransferase I inhibitor | 0.185 0.077 CID_154699930 | ||
| 0.171 | 0.017 | 0.171 | Heat shock protein 70 antagonist | 0.17 0.017 CID_154699930 | ||
| 0.168 | 0.014 | 0.168 | DOPA decarboxylase inhibitor | 0.15 0.021 CID_154699930 | ||
| 0.168 | 0.014 | 0.186 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.186 0.011 CID_154699930 | CID_154699930 | |
| 0.293 | 0.14 | 0.297 | Antibacterial | 0.297 0.138 CID_154699930 | CID_154699930 | |
| 0.158 | 0.005 | 0.199 | CD45 antagonist | 0.199 0.005 CID_154699930 | CID_154699930 | |
| 0.17 | 0.018 | 0.17 | Protein kinase C mu inhibitor | |||
| 0.153 | 0.004 | 0.153 | Purinergic P2Y14 antagonist | 0.052 0.006 CID_154699930 | ||
| 0.185 | 0.036 | 0.185 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.185 | 0.036 | 0.185 | Cyclooxygenase 2 inhibitor | 0.177 0.039 CID_154699930 | ||
| 0.19 | 0.042 | 0.19 | Activin receptor-like kinase 2 inhibitor | 0.155 0.063 CID_154699930 | ||
| 0.167 | 0.019 | 0.168 | DNA repair enzyme inhibitor | 0.168 0.019 CID_154699930 | CID_154699930 | |
| 0.172 | 0.024 | 0.172 | Pregnane X receptor agonist | 0.15 0.053 CID_154699930 | ||
| 0.169 | 0.022 | 0.169 | Catalase inhibitor | |||
| 0.186 | 0.04 | 0.186 | Nav1.2 sodium channel blocker | |||
| 0.159 | 0.012 | 0.159 | Acetylcholine release stimulant | 0.12 0.048 CID_154699930 | ||
| 0.185 | 0.039 | 0.185 | NADPH oxidase inhibitor | 0.133 0.068 CID_154699930 | ||
| 0.158 | 0.012 | 0.158 | Histamine N-methyltransferase inhibitor | 0.106 0.04 CID_154699930 | ||
| 0.149 | 0.005 | 0.149 | Granulocyte macrophage colony stimulating factor agonist | 0.107 0.026 CID_154699930 | ||
| 0.226 | 0.082 | 0.226 | Neuropeptide Y2 antagonist | |||
| 0.152 | 0.008 | 0.152 | Sphingosine 1-phosphate receptor 4 agonist | 0.079 0.037 CID_154699930 | ||
| 0.189 | 0.046 | 0.245 | Melanin inhibitor | 0.245 0.029 CID_154699930 | CID_154699930 | |
| 0.181 | 0.038 | 0.181 | Toll-Like receptor antagonist | |||
| 0.19 | 0.048 | 0.19 | Protein kinase (CK1) gamma inhibitor | |||
| 0.188 | 0.047 | 0.188 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.176 | 0.034 | 0.176 | Alkylator | 0.159 0.042 CID_154699930 | ||
| 0.167 | 0.025 | 0.167 | Carbonic anhydrase XV inhibitor | 0.118 0.048 CID_154699930 | ||
| 0.207 | 0.066 | 0.207 | Insulin sensitizer | 0.183 0.092 CID_154699930 | ||
| 0.171 | 0.031 | 0.171 | 5-Lipoxygenase inhibitor | 0.144 0.04 CID_154699930 | ||
| 0.172 | 0.033 | 0.172 | Cathepsin H inhibitor | |||
| 0.191 | 0.053 | 0.191 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.226 | 0.088 | 0.226 | Calpain inhibitor | 0.166 0.154 CID_154699930 | ||
| 0.183 | 0.046 | 0.241 | CDC-like kinase 1 inhibitor | 0.241 0.02 CID_154699930 | CID_154699930 | |
| 0.148 | 0.011 | 0.148 | Estrogen agonist | 0.084 0.022 CID_154699930 | ||
| 0.187 | 0.052 | 0.234 | Protein-tyrosine phosphatase inhibitor | 0.234 0.035 CID_154699930 | CID_154699930 | |
| 0.169 | 0.034 | 0.169 | Adenylate cyclase inhibitor | 0.153 0.043 CID_154699930 | ||
| 0.172 | 0.038 | 0.172 | Toll-Like receptor 2 antagonist | 0.152 0.052 CID_154699930 | ||
| 0.2 | 0.066 | 0.2 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.143 | 0.01 | 0.143 | Biliverdin reductase inhibitor | 0.055 0.047 CID_154699930 | ||
| 0.207 | 0.075 | 0.236 | DNA methylase inhibitor | 0.236 0.056 CID_154699930 | CID_154699930 | |
| 0.181 | 0.05 | 0.181 | Cyclooxygenase inhibitor | 0.178 0.052 CID_154699930 | ||
| 0.142 | 0.012 | 0.142 | Bromodomain-containing protein 2 inhibitor | 0.094 0.048 CID_154699930 | ||
| 0.171 | 0.042 | 0.171 | MAP kinase 3 inhibitor | |||
| 0.133 | 0.005 | 0.133 | Aconitate hydratase inhibitor | 0.067 0.021 CID_154699930 | ||
| 0.148 | 0.02 | 0.148 | Electrolyte absorption antagonist | |||
| 0.146 | 0.02 | 0.146 | Anabolic | 0.109 0.051 CID_154699930 | ||
| 0.136 | 0.011 | 0.136 | ATPase (Vacuolar H+) inhibitor | 0.113 0.025 CID_154699930 | ||
| 0.179 | 0.054 | 0.179 | Diuretic | |||
| 0.151 | 0.026 | 0.151 | Nav1.5 sodium channel blocker | 0.1 0.085 CID_154699930 | ||
| 0.143 | 0.019 | 0.143 | Phosphofructokinase-1 inhibitor | 0.07 0.048 CID_154699930 | ||
| 0.156 | 0.034 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.102 CID_154699930 | ||
| 0.183 | 0.062 | 0.183 | Antipruritic | |||
| 0.156 | 0.035 | 0.156 | Aminopeptidase B inhibitor | 0.09 0.072 CID_154699930 | ||
| 0.224 | 0.103 | 0.302 | Spasmolytic | 0.302 0.069 CID_154699930 | CID_154699930 | |
| 0.278 | 0.158 | 0.278 | MAP kinase kinase 6 inhibitor | |||
| 0.143 | 0.024 | 0.143 | Phosphodiesterase 7B inhibitor | |||
| 0.153 | 0.034 | 0.153 | GABA receptor agonist | |||
| 0.133 | 0.015 | 0.217 | Estrogen receptor alpha antagonist | 0.217 0.007 CID_154699930 | CID_154699930 | |
| 0.154 | 0.036 | 0.154 | Microtubule formation inhibitor | 0.116 0.066 CID_154699930 | ||
| 0.131 | 0.013 | 0.131 | Glycine receptor antagonist | |||
| 0.145 | 0.029 | 0.187 | Antineoplastic alkaloid | 0.187 0.017 CID_154699930 | CID_154699930 | |
| 0.162 | 0.047 | 0.162 | Sodium channel (voltage-gated) blocker | |||
| 0.17 | 0.055 | 0.17 | Amylase inhibitor | 0.114 0.085 CID_154699930 | ||
| 0.132 | 0.017 | 0.132 | Glutamate decarboxylase inhibitor | 0.083 0.041 CID_154699930 | ||
| 0.124 | 0.009 | 0.124 | Estrogen receptor beta agonist | 0.06 0.017 CID_154699930 | ||
| 0.128 | 0.014 | 0.139 | mTOR complex 2 inhibitor | 0.139 0.011 CID_154699930 | CID_154699930 | |
| 0.133 | 0.02 | 0.133 | Glutamate (mGluR7) agonist | 0.117 0.033 CID_154699930 | ||
| 0.119 | 0.007 | 0.119 | Phospholipase D inhibitor | 0.07 0.054 CID_154699930 | ||
| 0.117 | 0.005 | 0.117 | Exportin-1 inhibitor | 0.084 0.02 CID_154699930 | ||
| 0.156 | 0.043 | 0.156 | Cyclooxygenase 3 inhibitor | 0.144 0.053 CID_154699930 | ||
| 0.124 | 0.012 | 0.124 | D-Ala-D-Ala ligase inhibitor | 0.106 0.023 CID_154699930 | ||
| 0.117 | 0.005 | 0.117 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.044 CID_154699930 | ||
| 0.122 | 0.011 | 0.122 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.066 0.029 CID_154699930 | ||
| 0.145 | 0.035 | 0.145 | TRPA1 agonist | 0.117 0.062 CID_154699930 | ||
| 0.194 | 0.084 | 0.216 | Pyruvate kinase inhibitor | 0.216 0.073 CID_154699930 | CID_154699930 | |
| 0.121 | 0.012 | 0.121 | Glycine receptor agonist | 0.071 0.053 CID_154699930 | ||
| 0.115 | 0.006 | 0.115 | Glutamate (mGluR6) antagonist | 0.09 0.016 CID_154699930 | ||
| 0.195 | 0.086 | 0.195 | Anticonvulsant | |||
| 0.116 | 0.008 | 0.116 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.031 CID_154699930 | ||
| 0.168 | 0.06 | 0.173 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.173 0.057 CID_154699930 | CID_154699930 | |
| 0.162 | 0.055 | 0.162 | Cell wall synthesis inhibitor | 0.116 0.106 CID_154699930 | ||
| 0.122 | 0.015 | 0.122 | Protein kinase C alpha inhibitor | |||
| 0.13 | 0.023 | 0.13 | Histidine decarboxylase inhibitor | |||
| 0.139 | 0.033 | 0.139 | Transcription factor STAT6 inhibitor | 0.105 0.094 CID_154699930 | ||
| 0.122 | 0.015 | 0.122 | Carbamoyl phosphate synthetase inhibitor | 0.064 0.04 CID_154699930 | ||
| 0.122 | 0.016 | 0.122 | Nicotinic alpha4beta2 receptor antagonist | 0.105 0.027 CID_154699930 | ||
| 0.148 | 0.042 | 0.148 | Beta amyloid protein antagonist | |||
| 0.113 | 0.008 | 0.128 | Topoisomerase II beta inhibitor | 0.128 0.006 CID_154699930 | CID_154699930 | |
| 0.117 | 0.013 | 0.117 | Acyl-CoA dehydrogenase inhibitor | 0.05 0.043 CID_154699930 | ||
| 0.11 | 0.006 | 0.11 | Glutamate (mGluR7) antagonist | 0.109 0.007 CID_154699930 | ||
| 0.112 | 0.008 | 0.112 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.039 CID_154699930 | ||
| 0.22 | 0.116 | 0.22 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.136 | 0.033 | 0.136 | Beta glucuronidase inhibitor | 0.114 0.052 CID_154699930 | ||
| 0.148 | 0.045 | 0.148 | Cholesterol synthesis inhibitor | |||
| 0.141 | 0.038 | 0.141 | CC chemokine 6 receptor antagonist | |||
| 0.106 | 0.004 | 0.106 | Acid-sensing ion channel blocker | 0.041 0.027 CID_154699930 | ||
| 0.124 | 0.022 | 0.124 | Glutamate dehydrogenase inhibitor | 0.066 0.062 CID_154699930 | ||
| 0.188 | 0.087 | 0.188 | Psychostimulant | |||
| 0.104 | 0.004 | 0.104 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CID_154699930 | ||
| 0.14 | 0.04 | 0.14 | MAP kinase kinase kinase inhibitor | 0.112 0.056 CID_154699930 | ||
| 0.135 | 0.035 | 0.135 | Carbonic anhydrase III inhibitor | 0.105 0.056 CID_154699930 | ||
| 0.116 | 0.016 | 0.116 | Caspase 7 inhibitor | 0.096 0.033 CID_154699930 | ||
| 0.155 | 0.056 | 0.206 | Tubulin antagonist | 0.206 0.035 CID_154699930 | CID_154699930 | |
| 0.139 | 0.042 | 0.139 | Falcipain 3 inhibitor | |||
| 0.159 | 0.062 | 0.159 | Protein kinase stimulant | 0.124 0.089 CID_154699930 | ||
| 0.198 | 0.101 | 0.198 | Antiamyloidogenic | 0.173 0.12 CID_154699930 | ||
| 0.102 | 0.005 | 0.102 | Calcium channel P-type blocker | 0.067 0.034 CID_154699930 | ||
| 0.161 | 0.065 | 0.161 | Interferon gamma antagonist | 0.132 0.106 CID_154699930 | ||
| 0.1 | 0.004 | 0.1 | NMDA 2D receptor antagonist | |||
| 0.112 | 0.017 | 0.112 | I kappa B kinase 1 inhibitor | |||
| 0.147 | 0.053 | 0.147 | Glutamate receptor antagonist | |||
| 0.115 | 0.021 | 0.115 | Aminopeptidase I inhibitor | |||
| 0.124 | 0.032 | 0.124 | Interleukin 1 beta converting enzyme inhibitor | 0.108 0.047 CID_154699930 | ||
| 0.096 | 0.005 | 0.096 | Adenylate cyclase 1 inhibitor | 0.078 0.009 CID_154699930 | ||
| 0.099 | 0.008 | 0.099 | Nicotinic alpha3beta2 receptor antagonist | 0.072 0.016 CID_154699930 | ||
| 0.15 | 0.058 | 0.15 | Sodium channel blocker | |||
| 0.116 | 0.025 | 0.116 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.101 | 0.01 | 0.101 | Phosphodiesterase 1C inhibitor | 0.067 0.035 CID_154699930 | ||
| 0.137 | 0.046 | 0.158 | Alpha 2b adrenoreceptor antagonist | 0.158 0.035 CID_154699930 | CID_154699930 | |
| 0.111 | 0.02 | 0.111 | GABA aminotransferase inhibitor | 0.071 0.06 CID_154699930 | ||
| 0.099 | 0.009 | 0.099 | Estrogen receptor alpha agonist | 0.033 0.024 CID_154699930 | ||
| 0.155 | 0.064 | 0.155 | Thiol protease inhibitor | 0.126 0.105 CID_154699930 | ||
| 0.107 | 0.018 | 0.107 | Estrogen-related receptor beta agonist | 0.083 0.058 CID_154699930 | ||
| 0.142 | 0.053 | 0.142 | Nav1.3 sodium channel blocker | |||
| 0.103 | 0.014 | 0.103 | GABA B receptor agonist | 0.078 0.046 CID_154699930 | ||
| 0.101 | 0.013 | 0.101 | Protein kinase C beta inhibitor | 0.088 0.021 CID_154699930 | ||
| 0.102 | 0.016 | 0.102 | Purinergic P2X1 antagonist | 0.074 0.029 CID_154699930 | ||
| 0.104 | 0.018 | 0.104 | Argininosuccinate synthase inhibitor | |||
| 0.128 | 0.043 | 0.128 | AMP-activated protein kinase stimulant | 0.102 0.068 CID_154699930 | ||
| 0.134 | 0.049 | 0.134 | 5 Hydroxytryptamine 2B antagonist | 0.122 0.059 CID_154699930 | ||
| 0.15 | 0.065 | 0.15 | Ribosomal protein S6 kinase inhibitor | |||
| 0.136 | 0.051 | 0.192 | Papain-like protease (SARS coronavirus) inhibitor | 0.192 0.012 CID_154699930 | CID_154699930 | |
| 0.101 | 0.016 | 0.101 | Vanilloid 4 agonist | |||
| 0.112 | 0.028 | 0.112 | GABA A receptor agonist | |||
| 0.099 | 0.016 | 0.099 | NMDA 2C receptor antagonist | |||
| 0.099 | 0.016 | 0.099 | 5 Hydroxytryptamine 3 agonist | 0.064 0.042 CID_154699930 | ||
| 0.098 | 0.015 | 0.098 | Androgen agonist | 0.064 0.036 CID_154699930 | ||
| 0.16 | 0.077 | 0.16 | Cyclin-dependent kinase 3 inhibitor | 0.155 0.085 CID_154699930 | ||
| 0.088 | 0.005 | 0.088 | Dopamine D5 agonist | 0.076 0.007 CID_154699930 | ||
| 0.112 | 0.03 | 0.112 | Acetylcholine nicotinic agonist | 0.082 0.054 CID_154699930 | ||
| 0.118 | 0.036 | 0.124 | Calcium antagonist | 0.124 0.033 CID_154699930 | CID_154699930 | |
| 0.118 | 0.037 | 0.118 | MAP kinase kinase 1 inhibitor | |||
| 0.148 | 0.067 | 0.148 | Vascular endothelial growth factor 3 antagonist | |||
| 0.093 | 0.013 | 0.093 | Fatty acid synthase inhibitor | 0.062 0.033 CID_154699930 | ||
| 0.088 | 0.008 | 0.088 | Glutamate (mGluR group II) agonist | |||
| 0.125 | 0.045 | 0.127 | Xanthine oxidase inhibitor | 0.127 0.044 CID_154699930 | CID_154699930 | |
| 0.138 | 0.058 | 0.138 | Antibacterial (Helicobacter pylori) | |||
| 0.2 | 0.12 | 0.2 | Immunostimulant | 0.193 0.125 CID_154699930 | ||
| 0.099 | 0.02 | 0.099 | Acetylcholine M5 receptor agonist | 0.065 0.049 CID_154699930 | ||
| 0.114 | 0.035 | 0.114 | Thioredoxin inhibitor | |||
| 0.226 | 0.148 | 0.226 | Antithrombotic | |||
| 0.108 | 0.03 | 0.108 | p38 MAP kinase inhibitor | |||
| 0.1 | 0.022 | 0.1 | CC chemokine 5 receptor agonist | |||
| 0.085 | 0.008 | 0.085 | Glutamate (mGluR2) agonist | |||
| 0.088 | 0.011 | 0.088 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.126 | 0.049 | 0.126 | Mucolytic | |||
| 0.087 | 0.01 | 0.087 | Aldosterone antagonist | 0.046 0.035 CID_154699930 | ||
| 0.114 | 0.037 | 0.114 | Androgen antagonist | 0.088 0.057 CID_154699930 | ||
| 0.11 | 0.035 | 0.11 | Phosphodiesterase 6D inhibitor | 0.096 0.06 CID_154699930 | ||
| 0.087 | 0.012 | 0.087 | Sphingosine kinase 2 inhibitor | |||
| 0.107 | 0.033 | 0.107 | Glutamate receptor agonist | |||
| 0.102 | 0.027 | 0.102 | Thioredoxin reductase inhibitor | 0.082 0.058 CID_154699930 | ||
| 0.091 | 0.017 | 0.091 | Phosphodiesterase 1B inhibitor | |||
| 0.082 | 0.008 | 0.082 | Glucose-6-phosphate isomerase inhibitor | 0.057 0.021 CID_154699930 | ||
| 0.109 | 0.035 | 0.109 | Ornithine decarboxylase inhibitor | 0.091 0.055 CID_154699930 | ||
| 0.109 | 0.035 | 0.109 | Phosphodiesterase I inhibitor | 0.087 0.063 CID_154699930 | ||
| 0.149 | 0.075 | 0.149 | Acetylcholine M1 receptor antagonist | |||
| 0.108 | 0.035 | 0.108 | Bile acid receptor antagonist | |||
| 0.116 | 0.043 | 0.116 | Potassium channel (Ca-activated) activator | |||
| 0.103 | 0.03 | 0.103 | Phosphodiesterase 3A inhibitor | |||
| 0.08 | 0.007 | 0.08 | Retinoid X alpha receptor agonist | 0.045 0.016 CID_154699930 | ||
| 0.131 | 0.06 | 0.131 | TRKA antagonist | |||
| 0.126 | 0.055 | 0.126 | Interleukin 8 antagonist | |||
| 0.16 | 0.089 | 0.16 | Tumour necrosis factor antagonist | |||
| 0.075 | 0.005 | 0.075 | Nerve growth factor antagonist | 0.056 0.012 CID_154699930 | ||
| 0.14 | 0.07 | 0.14 | Cytokine production inhibitor | 0.127 0.083 CID_154699930 | ||
| 0.122 | 0.052 | 0.148 | MAO A inhibitor | 0.148 0.041 CID_154699930 | CID_154699930 | |
| 0.074 | 0.006 | 0.074 | Benzodiazepine antagonist | 0.064 0.01 CID_154699930 | ||
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.082 | 0.015 | 0.082 | Phosphodiesterase 1A inhibitor | |||
| 0.079 | 0.012 | 0.079 | DNA helicase inhibitor | |||
| 0.143 | 0.076 | 0.143 | Hemostatic | |||
| 0.073 | 0.006 | 0.073 | Geranyltranstransferase inhibitor | |||
| 0.075 | 0.009 | 0.075 | Thymidylate synthase inhibitor | |||
| 0.086 | 0.02 | 0.102 | Alpha 2 adrenoreceptor agonist | 0.102 0.014 CID_154699930 | CID_154699930 | |
| 0.115 | 0.05 | 0.115 | Urease inhibitor | 0.093 0.076 CID_154699930 | ||
| 0.087 | 0.021 | 0.124 | Aryl hydrocarbon receptor antagonist | 0.124 0.007 CID_154699930 | CID_154699930 | |
| 0.087 | 0.021 | 0.087 | Protein kinase C eta inhibitor | |||
| 0.069 | 0.004 | 0.069 | Estrogen-related receptor beta antagonist | 0.034 0.019 CID_154699930 | ||
| 0.074 | 0.009 | 0.074 | Immunoglobulin Fc receptor antagonist | |||
| 0.107 | 0.042 | 0.107 | ABCA1 expression enhancer | |||
| 0.081 | 0.018 | 0.081 | Potassium channel (Ca-activated) blocker | |||
| 0.072 | 0.008 | 0.072 | Liver X receptor alpha agonist | 0.066 0.01 CID_154699930 | ||
| 0.096 | 0.033 | 0.096 | Interferon agonist | 0.079 0.053 CID_154699930 | ||
| 0.082 | 0.019 | 0.089 | Heat shock protein 90 beta antagonist | 0.089 0.015 CID_154699930 | CID_154699930 | |
| 0.072 | 0.01 | 0.072 | Retinoid X receptor agonist | 0.045 0.02 CID_154699930 | ||
| 0.08 | 0.017 | 0.08 | Transcription factor RelA inhibitor | 0.067 0.036 CID_154699930 | ||
| 0.095 | 0.033 | 0.095 | Acetylcholine M4 receptor antagonist | 0.089 0.038 CID_154699930 | ||
| 0.098 | 0.036 | 0.098 | Macrophage migration inhibitory factor inhibitor | 0.076 0.056 CID_154699930 | ||
| 0.074 | 0.012 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 CID_154699930 | ||
| 0.076 | 0.015 | 0.076 | 5 Hydroxytryptamine 7 agonist | |||
| 0.085 | 0.024 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | 0.068 0.039 CID_154699930 | ||
| 0.088 | 0.027 | 0.088 | Secretase beta inhibitor | 0.072 0.046 CID_154699930 | ||
| 0.114 | 0.054 | 0.114 | Check point kinase 2 inhibitor | |||
| 0.122 | 0.062 | 0.164 | Protein-tyrosine phosphatase 1B inhibitor | 0.164 0.04 CID_154699930 | CID_154699930 | |
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | |||
| 0.074 | 0.014 | 0.074 | Alpha-mannosidase inhibitor | 0.055 0.035 CID_154699930 | ||
| 0.097 | 0.038 | 0.097 | Myeloperoxidase inhibitor | 0.076 0.074 CID_154699930 | ||
| 0.064 | 0.005 | 0.064 | Liver X receptor beta antagonist | 0.033 0.017 CID_154699930 | ||
| 0.095 | 0.036 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 CID_154699930 | ||
| 0.134 | 0.076 | 0.162 | Glycogen synthase kinase-3 alpha inhibitor | 0.162 0.058 CID_154699930 | CID_154699930 | |
| 0.079 | 0.021 | 0.079 | MDM2 inhibitor | |||
| 0.089 | 0.032 | 0.089 | Benzodiazepine agonist | |||
| 0.098 | 0.041 | 0.098 | Carbonic anhydrase VI inhibitor | 0.093 0.044 CID_154699930 | ||
| 0.065 | 0.008 | 0.065 | GABA uptake inhibitor | 0.039 0.028 CID_154699930 | ||
| 0.069 | 0.012 | 0.069 | Dihydroorotase inhibitor | |||
| 0.103 | 0.046 | 0.103 | Toll-Like receptor 3 antagonist | |||
| 0.092 | 0.036 | 0.092 | Keratolytic | |||
| 0.06 | 0.003 | 0.076 | Imidazoline I1 receptor antagonist | 0.076 0.003 CID_154699930 | CID_154699930 | |
| 0.112 | 0.056 | 0.147 | Alpha 2c adrenoreceptor antagonist | 0.147 0.034 CID_154699930 | CID_154699930 | |
| 0.063 | 0.007 | 0.063 | Histamine H1 receptor agonist | 0.044 0.03 CID_154699930 | ||
| 0.071 | 0.016 | 0.071 | Dihydroorotate oxidase inhibitor | |||
| 0.069 | 0.013 | 0.069 | Potassium channel small-conductance Ca-activated blocker | 0.041 0.038 CID_154699930 | ||
| 0.082 | 0.027 | 0.082 | NMDA receptor glycine site agonist | 0.055 0.051 CID_154699930 | ||
| 0.153 | 0.098 | 0.22 | Amyloid beta precursor protein antagonist | 0.22 0.046 CID_154699930 | CID_154699930 | |
| 0.119 | 0.064 | 0.119 | Calcium channel N-type blocker | |||
| 0.1 | 0.045 | 0.1 | Protein kinase A inhibitor | |||
| 0.1 | 0.046 | 0.1 | Pim-3 kinase inhibitor | |||
| 0.096 | 0.042 | 0.096 | Glutathione S-transferase inhibitor | |||
| 0.111 | 0.057 | 0.111 | Mediator release inhibitor | |||
| 0.057 | 0.004 | 0.057 | Alpha 2a adrenoreceptor agonist | |||
| 0.063 | 0.009 | 0.063 | Guanylate cyclase inhibitor | |||
| 0.138 | 0.085 | 0.138 | Cytidine deaminase inhibitor | |||
| 0.068 | 0.015 | 0.068 | Squalene epoxidase inhibitor | |||
| 0.126 | 0.073 | 0.126 | Vanilloid 1 agonist | |||
| 0.09 | 0.037 | 0.09 | NMDA 2 receptor antagonist | |||
| 0.064 | 0.012 | 0.064 | Glutamate (mGluR4) antagonist | 0.041 0.034 CID_154699930 | ||
| 0.073 | 0.021 | 0.073 | Sphingosine kinase inhibitor | |||
| 0.059 | 0.007 | 0.059 | Angiotensin AT1 receptor antagonist | 0.045 0.025 CID_154699930 | ||
| 0.129 | 0.077 | 0.129 | Alkaline phosphatase inhibitor | 0.116 0.091 CID_154699930 | ||
| 0.062 | 0.011 | 0.078 | GABA B receptor antagonist | 0.078 0.007 CID_154699930 | CID_154699930 | |
| 0.129 | 0.078 | 0.129 | Tyrosine-protein kinase receptor antagonist | |||
| 0.115 | 0.065 | 0.115 | Protein kinase (CK2) alpha inhibitor | 0.094 0.082 CID_154699930 | ||
| 0.082 | 0.032 | 0.082 | Nav1.7 sodium channel blocker | |||
| 0.058 | 0.008 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.038 0.037 CID_154699930 | ||
| 0.075 | 0.025 | 0.075 | Carbonic anhydrase VB inhibitor | 0.053 0.042 CID_154699930 | ||
| 0.109 | 0.06 | 0.163 | CDC-like kinase 3 inhibitor | 0.163 0.014 CID_154699930 | CID_154699930 | |
| 0.109 | 0.059 | 0.109 | Expectorant | |||
| 0.071 | 0.021 | 0.071 | Glucosylceramidase inhibitor | |||
| 0.058 | 0.009 | 0.058 | Liver X receptor beta agonist | 0.041 0.015 CID_154699930 | ||
| 0.098 | 0.048 | 0.098 | NMDA receptor antagonist | |||
| 0.122 | 0.073 | 0.159 | MAO inhibitor | 0.159 0.056 CID_154699930 | CID_154699930 | |
| 0.076 | 0.028 | 0.076 | Carbonic anhydrase stimulant | |||
| 0.091 | 0.043 | 0.098 | Carbonic anhydrase XIII inhibitor | 0.098 0.039 CID_154699930 | CID_154699930 | |
| 0.071 | 0.023 | 0.071 | Nicotinic alpha7 receptor agonist | 0.058 0.034 CID_154699930 | ||
| 0.081 | 0.033 | 0.081 | Potassium channel (Tandem pore domain) blocker | |||
| 0.112 | 0.064 | 0.182 | 5 Hydroxytryptamine 2 antagonist | 0.182 0.035 CID_154699930 | CID_154699930 | |
| 0.061 | 0.014 | 0.061 | Progesterone antagonist | 0.049 0.018 CID_154699930 | ||
| 0.062 | 0.015 | 0.062 | Mannosidase inhibitor | 0.04 0.039 CID_154699930 | ||
| 0.064 | 0.018 | 0.064 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.06 | 0.013 | 0.06 | Glutamate (mGluR group III) antagonist | 0.045 0.028 CID_154699930 | ||
| 0.055 | 0.009 | 0.055 | Kainate receptor agonist | |||
| 0.06 | 0.015 | 0.06 | Dopamine beta hydroxylase inhibitor | |||
| 0.074 | 0.028 | 0.074 | I kappa B kinase 2 inhibitor | |||
| 0.066 | 0.021 | 0.066 | Epithelial sodium channel blocker | |||
| 0.052 | 0.007 | 0.052 | Melatonin receptor 1A agonist | 0.041 0.013 CID_154699930 | ||
| 0.066 | 0.021 | 0.099 | 5 Hydroxytryptamine 2 agonist | 0.099 0.009 CID_154699930 | CID_154699930 | |
| 0.067 | 0.022 | 0.067 | Ryanodine receptor antagonist | 0.067 0.022 CID_154699930 | ||
| 0.111 | 0.066 | 0.111 | MAP kinase 13 inhibitor | |||
| 0.117 | 0.072 | 0.117 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.057 | 0.012 | 0.057 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.066 | 0.021 | 0.066 | Lysine-specific demethylase 1A inhibitor | |||
| 0.066 | 0.022 | 0.066 | AMPA receptor antagonist | 0.043 0.04 CID_154699930 | ||
| 0.056 | 0.011 | 0.056 | Fumarate hydratase inhibitor | |||
| 0.116 | 0.072 | 0.116 | Abl kinase inhibitor | |||
| 0.061 | 0.017 | 0.061 | Fructose-1,6-bisphosphatase inhibitor | 0.055 0.02 CID_154699930 | ||
| 0.054 | 0.01 | 0.054 | Glutamate (mGluR3) antagonist | 0.033 0.032 CID_154699930 | ||
| 0.051 | 0.008 | 0.051 | Vanilloid 3 antagonist | 0.05 0.009 CID_154699930 | ||
| 0.053 | 0.01 | 0.053 | Retinoid X receptor antagonist | 0.043 0.019 CID_154699930 | ||
| 0.124 | 0.081 | 0.124 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.053 | 0.01 | 0.053 | Glutamate (mGluR8) agonist | 0.038 0.026 CID_154699930 | ||
| 0.049 | 0.006 | 0.049 | Liver X receptor alpha antagonist | 0.03 0.019 CID_154699930 | ||
| 0.052 | 0.009 | 0.052 | Liver X receptor antagonist | |||
| 0.062 | 0.019 | 0.062 | Heparanase inhibitor | 0.06 0.024 CID_154699930 | ||
| 0.08 | 0.037 | 0.08 | Leukotriene synthesis inhibitor | |||
| 0.068 | 0.025 | 0.068 | NMDA 2A receptor antagonist | |||
| 0.053 | 0.01 | 0.053 | Heme oxygenase inhibitor | |||
| 0.054 | 0.012 | 0.064 | Sirtuin 2 inhibitor | 0.064 0.009 CID_154699930 | CID_154699930 | |
| 0.058 | 0.016 | 0.058 | Purinergic P2X4 antagonist | 0.054 0.02 CID_154699930 | ||
| 0.057 | 0.015 | 0.057 | Urate transporter 1 inhibitor | |||
| 0.118 | 0.076 | 0.118 | MAP kinase kinase inhibitor | |||
| 0.219 | 0.177 | 0.219 | Immunosuppressant | |||
| 0.049 | 0.007 | 0.049 | Angiotensin II receptor antagonist | 0.033 0.027 CID_154699930 | ||
| 0.077 | 0.035 | 0.077 | Bcl2 antagonist | |||
| 0.098 | 0.056 | 0.098 | Potassium channel (Voltage-sensitive) activator | |||
| 0.09 | 0.048 | 0.09 | I kappa B kinase inhibitor | |||
| 0.049 | 0.008 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 CID_154699930 | ||
| 0.057 | 0.016 | 0.057 | Cytokine production stimulant | |||
| 0.071 | 0.03 | 0.071 | Dopamine uptake inhibitor | 0.057 0.041 CID_154699930 | ||
| 0.076 | 0.035 | 0.083 | Dopamine D1 antagonist | 0.083 0.031 CID_154699930 | CID_154699930 | |
| 0.106 | 0.065 | 0.106 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.053 | 0.013 | 0.06 | 5 Hydroxytryptamine 3B antagonist | 0.06 0.011 CID_154699930 | CID_154699930 | |
| 0.133 | 0.093 | 0.133 | Neuropeptide Y1 antagonist | |||
| 0.074 | 0.033 | 0.074 | 5 Hydroxytryptamine 2A agonist | 0.056 0.051 CID_154699930 | ||
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | |||
| 0.048 | 0.008 | 0.048 | Melatonin antagonist | 0.041 0.009 CID_154699930 | ||
| 0.049 | 0.009 | 0.049 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.072 | 0.033 | 0.072 | Aromatase inhibitor | 0.065 0.038 CID_154699930 | ||
| 0.071 | 0.032 | 0.071 | Carbonic anhydrase IX inhibitor | |||
| 0.072 | 0.033 | 0.072 | Interferon inducer | |||
| 0.093 | 0.054 | 0.093 | Ca(v)2.2 blocker | |||
| 0.079 | 0.04 | 0.079 | Prostaglandin-E synthase inhibitor | |||
| 0.052 | 0.013 | 0.052 | Diamine oxidase inhibitor | |||
| 0.053 | 0.014 | 0.053 | Glutamate (mGluR group II) antagonist | |||
| 0.066 | 0.029 | 0.066 | Botulinum neurotoxin type A inhibitor | |||
| 0.108 | 0.07 | 0.112 | Monophenol monooxygenase inhibitor | 0.112 0.067 CID_154699930 | CID_154699930 | |
| 0.065 | 0.028 | 0.065 | Ornithine carbamoyltransferase inhibitor | |||
| 0.046 | 0.009 | 0.046 | Retinoid X alpha receptor antagonist | 0.038 0.017 CID_154699930 | ||
| 0.107 | 0.07 | 0.107 | Polo-like kinase-4 inhibitor | |||
| 0.057 | 0.021 | 0.057 | NMDA receptor subunit 3B antagonist | |||
| 0.067 | 0.03 | 0.067 | Nicotinic neuronal receptor agonist | |||
| 0.045 | 0.009 | 0.045 | Benzodiazepine receptor peripheral-type antagonist | 0.036 0.02 CID_154699930 | ||
| 0.054 | 0.018 | 0.054 | Histamine H2 receptor agonist | |||
| 0.076 | 0.04 | 0.076 | Carbonic anhydrase VA inhibitor | |||
| 0.065 | 0.029 | 0.065 | Protein kinase C theta inhibitor | |||
| 0.078 | 0.042 | 0.078 | Calcium channel L-type blocker | 0.065 0.06 CID_154699930 | ||
| 0.058 | 0.022 | 0.058 | Potassium channel Kv1.3 blocker | |||
| 0.074 | 0.038 | 0.074 | 5 Hydroxytryptamine 1B antagonist | 0.065 0.045 CID_154699930 | ||
| 0.074 | 0.039 | 0.074 | Carbonic anhydrase V inhibitor | |||
| 0.08 | 0.045 | 0.08 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.132 | 0.097 | 0.132 | Phospholipase A2 inhibitor | |||
| 0.044 | 0.009 | 0.044 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.04 | 0.005 | 0.04 | Glutamate (mGluR1a) agonist | 0.03 0.009 CID_154699930 | ||
| 0.046 | 0.011 | 0.074 | Melatonin agonist | 0.074 0.005 CID_154699930 | CID_154699930 | |
| 0.049 | 0.014 | 0.049 | 5 Hydroxytryptamine 2B agonist | |||
| 0.063 | 0.029 | 0.063 | Protein kinase C epsilon inhibitor | |||
| 0.067 | 0.033 | 0.084 | Xanthine dehydrogenase inhibitor | 0.084 0.022 CID_154699930 | CID_154699930 | |
| 0.052 | 0.018 | 0.052 | Thymidine kinase inhibitor | |||
| 0.061 | 0.027 | 0.061 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.07 | 0.036 | 0.07 | NMDA receptor agonist | |||
| 0.067 | 0.034 | 0.067 | 5 Hydroxytryptamine 5A antagonist | 0.059 0.047 CID_154699930 | ||
| 0.042 | 0.009 | 0.042 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.086 | 0.053 | 0.086 | Histamine H2 receptor antagonist | |||
| 0.061 | 0.028 | 0.061 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.098 | 0.066 | 0.098 | Protein kinase (CK2) inhibitor | |||
| 0.098 | 0.066 | 0.104 | mTOR complex 1 inhibitor | 0.104 0.053 CID_154699930 | CID_154699930 | |
| 0.036 | 0.004 | 0.036 | Complement factor 1s inhibitor | 0.024 0.023 CID_154699930 | ||
| 0.089 | 0.057 | 0.176 | Alpha 2 adrenoreceptor antagonist | 0.176 0.022 CID_154699930 | CID_154699930 | |
| 0.067 | 0.035 | 0.067 | TRPA1 antagonist | |||
| 0.04 | 0.009 | 0.04 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.068 | 0.037 | 0.068 | Beta 3 adrenoreceptor antagonist | |||
| 0.05 | 0.018 | 0.05 | Histone deacetylase 7 inhibitor | |||
| 0.087 | 0.055 | 0.087 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.048 | 0.017 | 0.048 | Histone deacetylase 9 inhibitor | |||
| 0.08 | 0.049 | 0.126 | Alpha 2a adrenoreceptor antagonist | 0.126 0.028 CID_154699930 | CID_154699930 | |
| 0.055 | 0.024 | 0.055 | Histamine H4 receptor antagonist | |||
| 0.073 | 0.042 | 0.073 | Neuronal nicotinic receptor antagonist | 0.06 0.054 CID_154699930 | ||
| 0.056 | 0.026 | 0.056 | Potassium channel (Inward rectifier) activator | |||
| 0.042 | 0.012 | 0.042 | ATP citrate lysase inhibitor | 0.034 0.019 CID_154699930 | ||
| 0.057 | 0.027 | 0.057 | Potassium channel (Inward rectifier) blocker | |||
| 0.072 | 0.042 | 0.072 | CDC7 inhibitor | |||
| 0.057 | 0.027 | 0.057 | Prolyl endopeptidase inhibitor | 0.047 0.04 CID_154699930 | ||
| 0.055 | 0.026 | 0.055 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 CID_154699930 | ||
| 0.09 | 0.061 | 0.09 | Potassium channel activator | |||
| 0.037 | 0.007 | 0.037 | HCV NS5A inhibitor | 0.031 0.013 CID_154699930 | ||
| 0.051 | 0.022 | 0.051 | Liver X receptor agonist | |||
| 0.032 | 0.003 | 0.055 | Imidazoline I2 receptor antagonist | 0.055 0.003 CID_154699930 | CID_154699930 | |
| 0.048 | 0.019 | 0.048 | Sphingosine kinase 1 inhibitor | |||
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | |||
| 0.036 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | |||
| 0.106 | 0.078 | 0.106 | Anesthetic local | |||
| 0.035 | 0.007 | 0.035 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.01 CID_154699930 | ||
| 0.062 | 0.034 | 0.062 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | |||
| 0.065 | 0.037 | 0.065 | Histone deacetylase SIRT3 inhibitor | |||
| 0.053 | 0.025 | 0.053 | Potassium channel (ATP-sensitive) activator | |||
| 0.045 | 0.018 | 0.045 | MAP3K5 inhibitor | |||
| 0.067 | 0.039 | 0.067 | Glutamate (mGluR) agonist | |||
| 0.06 | 0.033 | 0.06 | Carbonic anhydrase XII inhibitor | |||
| 0.064 | 0.036 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.033 | 0.006 | 0.033 | Melatonin 1 antagonist | 0.031 0.006 CID_154699930 | ||
| 0.064 | 0.037 | 0.064 | Cyclin D1 inhibitor | |||
| 0.058 | 0.031 | 0.064 | Nicotinic receptor alpha7 subunit antagonist | 0.064 0.025 CID_154699930 | CID_154699930 | |
| 0.05 | 0.023 | 0.05 | Glutamate (mGluR group III) agonist | |||
| 0.063 | 0.036 | 0.067 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.067 0.033 CID_154699930 | CID_154699930 | |
| 0.041 | 0.015 | 0.041 | Free fatty acid receptor 1 antagonist | |||
| 0.086 | 0.059 | 0.086 | Acetylcholine agonist | |||
| 0.061 | 0.035 | 0.061 | 5 Hydroxytryptamine 5 antagonist | 0.058 0.04 CID_154699930 | ||
| 0.053 | 0.026 | 0.053 | Cholesterol esterase inhibitor | 0.045 0.039 CID_154699930 | ||
| 0.03 | 0.004 | 0.03 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.007 CID_154699930 | ||
| 0.035 | 0.008 | 0.035 | Adenosine kinase inhibitor | 0.032 0.009 CID_154699930 | ||
| 0.064 | 0.038 | 0.064 | Prolactin release inhibitor | |||
| 0.038 | 0.013 | 0.038 | Glutamate (mGluR2) antagonist | |||
| 0.057 | 0.031 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.034 | 0.008 | 0.034 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.074 | 0.049 | 0.074 | Cathepsin G inhibitor | |||
| 0.107 | 0.082 | 0.107 | Acetylcholine muscarinic antagonist | 0.102 0.088 CID_154699930 | ||
| 0.094 | 0.069 | 0.094 | Nitric-oxide synthase inhibitor | |||
| 0.08 | 0.055 | 0.08 | Acetylcholine nicotinic antagonist | |||
| 0.047 | 0.023 | 0.047 | Glutamate (mGluR1a) antagonist | |||
| 0.039 | 0.015 | 0.039 | Potassium channel small-conductance Ca-activated activator | |||
| 0.029 | 0.005 | 0.031 | Alpha 2c adrenoreceptor agonist | 0.031 0.005 CID_154699930 | CID_154699930 | |
| 0.037 | 0.013 | 0.037 | Uridine phosphorylase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Glucosylceramidase stimulant | 0.026 0.024 CID_154699930 | ||
| 0.08 | 0.057 | 0.08 | Histamine H1 receptor antagonist | |||
| 0.045 | 0.022 | 0.045 | NMDA receptor subunit 3A antagonist | |||
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | |||
| 0.061 | 0.039 | 0.061 | Protein kinase C iota inhibitor | |||
| 0.046 | 0.024 | 0.046 | Dihydrofolate reductase inhibitor | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.081 | 0.059 | 0.148 | 5 Hydroxytryptamine 2A antagonist | 0.148 0.029 CID_154699930 | CID_154699930 | |
| 0.063 | 0.041 | 0.063 | Cannabinoid CB1 receptor antagonist | |||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | 0.027 0.014 CID_154699930 | ||
| 0.045 | 0.023 | 0.045 | Plasmepsin II inhibitor | |||
| 0.056 | 0.035 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.031 | 0.009 | 0.031 | Vanilloid 2 agonist | |||
| 0.068 | 0.047 | 0.069 | Alpha adrenoreceptor agonist | 0.069 0.047 CID_154699930 | CID_154699930 | |
| 0.043 | 0.022 | 0.043 | AMPA 4 receptor antagonist | |||
| 0.049 | 0.028 | 0.049 | Oleamide hydrolase inhibitor | |||
| 0.081 | 0.061 | 0.081 | Inducible nitric-oxide synthase inhibitor | |||
| 0.074 | 0.053 | 0.074 | Phosphodiesterase VI inhibitor | |||
| 0.026 | 0.006 | 0.026 | Retinoid X beta receptor antagonist | 0.021 0.014 CID_154699930 | ||
| 0.046 | 0.027 | 0.046 | AICAR transformylase inhibitor | |||
| 0.057 | 0.037 | 0.057 | Leukotriene C antagonist | 0.056 0.04 CID_154699930 | ||
| 0.072 | 0.053 | 0.072 | Histone deacetylase SIRT2 inhibitor | |||
| 0.055 | 0.036 | 0.055 | Thromboxane synthase inhibitor | |||
| 0.041 | 0.022 | 0.041 | CF transmembrane conductance regulator antagonist | |||
| 0.039 | 0.02 | 0.039 | Phosphoglycerate kinase inhibitor | |||
| 0.033 | 0.013 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.009 CID_154699930 | ||
| 0.041 | 0.021 | 0.041 | Potassium channel Kv1.1 blocker | |||
| 0.04 | 0.021 | 0.04 | Delayed rectifier potassium channel blocker | |||
| 0.033 | 0.014 | 0.033 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.057 | 0.039 | 0.06 | 5 Hydroxytryptamine 6 antagonist | 0.06 0.036 CID_154699930 | CID_154699930 | |
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.046 | 0.028 | 0.046 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.035 CID_154699930 | ||
| 0.072 | 0.054 | 0.072 | Rho-associated kinase I inhibitor | |||
| 0.03 | 0.012 | 0.03 | Integrin alpha2beta1 antagonist | |||
| 0.104 | 0.086 | 0.104 | Caspase 3 inhibitor | |||
| 0.05 | 0.032 | 0.05 | Carbonic anhydrase XIV inhibitor | |||
| 0.062 | 0.044 | 0.062 | Carbonic anhydrase inhibitor | |||
| 0.035 | 0.017 | 0.035 | Cholesterol ester transfer protein antagonist | 0.033 0.02 CID_154699930 | ||
| 0.115 | 0.097 | 0.115 | Histone deacetylase SIRT1 inhibitor | 0.109 0.105 CID_154699930 | ||
| 0.044 | 0.026 | 0.044 | Histone deacetylase 8 inhibitor | |||
| 0.036 | 0.018 | 0.036 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.023 | 0.006 | 0.023 | Antibiotic Anthracycline-like | |||
| 0.06 | 0.043 | 0.06 | Acetylcholine M5 receptor antagonist | |||
| 0.058 | 0.041 | 0.058 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.054 | 0.037 | 0.056 | Leukotriene B4 antagonist | 0.056 0.033 CID_154699930 | CID_154699930 | |
| 0.03 | 0.013 | 0.036 | Sodium/glucose cotransporter 2 inhibitor | 0.036 0.01 CID_154699930 | CID_154699930 | |
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.02 | 0.003 | 0.02 | Progesterone receptor A antagonist | 0.018 0.004 CID_154699930 | ||
| 0.07 | 0.054 | 0.07 | Orexin receptor 1 antagonist | 0.069 0.058 CID_154699930 | ||
| 0.049 | 0.032 | 0.049 | Mineralocorticoid receptor antagonist | |||
| 0.068 | 0.052 | 0.068 | Amidase inhibitor | |||
| 0.062 | 0.046 | 0.062 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.04 | 0.025 | 0.04 | Retinoic acid alpha receptor agonist | |||
| 0.065 | 0.05 | 0.065 | Potassium channel (ATP-sensitive) blocker | |||
| 0.03 | 0.014 | 0.03 | Myristoyl transferase inhibitor | |||
| 0.025 | 0.01 | 0.025 | Angiotensin AT1A receptor antagonist | |||
| 0.041 | 0.026 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.035 | 0.02 | 0.035 | Transforming growth factor beta 2 antagonist | |||
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.035 | 0.02 | 0.035 | Calcium release-activated channel blocker | |||
| 0.02 | 0.005 | 0.02 | Thromboxane A2 agonist | |||
| 0.031 | 0.016 | 0.031 | MAP3K8 inhibitor | |||
| 0.018 | 0.005 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.034 | 0.021 | 0.034 | Protein kinase (CK2) beta inhibitor | |||
| 0.021 | 0.008 | 0.021 | Nicotinic acid receptor 1 antagonist | |||
| 0.047 | 0.033 | 0.047 | Adenosine deaminase inhibitor | |||
| 0.104 | 0.091 | 0.104 | Cholinergic antagonist | |||
| 0.025 | 0.012 | 0.027 | Geranylgeranyltransferase inhibitor | 0.027 0.011 CID_154699930 | CID_154699930 | |
| 0.042 | 0.029 | 0.042 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.045 | 0.033 | 0.045 | Glutamate (mGluR5) agonist | |||
| 0.035 | 0.022 | 0.035 | Glutamate (mGluR4) agonist | |||
| 0.024 | 0.012 | 0.024 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.039 | 0.027 | 0.039 | Membrane dipeptidase inhibitor | |||
| 0.084 | 0.072 | 0.102 | MAO B inhibitor | 0.102 0.059 CID_154699930 | CID_154699930 | |
| 0.039 | 0.027 | 0.039 | Vascular adhesion protein 1 inhibitor | |||
| 0.021 | 0.008 | 0.021 | Complement factor D inhibitor | |||
| 0.033 | 0.021 | 0.033 | Glutamate (mGluR3) agonist | |||
| 0.044 | 0.032 | 0.044 | Sphingosine 1-phosphate receptor agonist | |||
| 0.042 | 0.03 | 0.042 | Oxytocin agonist | |||
| 0.021 | 0.01 | 0.021 | Progesterone receptor B antagonist | |||
| 0.026 | 0.015 | 0.026 | Glutamate (mGluR1) agonist | 0.023 0.02 CID_154699930 | ||
| 0.023 | 0.011 | 0.023 | Retinoic acid alpha receptor antagonist | |||
| 0.021 | 0.01 | 0.021 | Retinoic acid receptor antagonist | |||
| 0.027 | 0.016 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.013 CID_154699930 | CID_154699930 | |
| 0.043 | 0.032 | 0.043 | Phosphodiesterase 3B inhibitor | |||
| 0.02 | 0.01 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.03 | 0.019 | 0.03 | 5 Hydroxytryptamine 1D agonist | |||
| 0.078 | 0.067 | 0.132 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.132 0.02 CID_154699930 | CID_154699930 | |
| 0.047 | 0.037 | 0.047 | Transforming growth factor beta 1 antagonist | |||
| 0.095 | 0.084 | 0.19 | 5 Hydroxytryptamine antagonist | 0.19 0.036 CID_154699930 | CID_154699930 | |
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase X inhibitor | |||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase VIII inhibitor | |||
| 0.024 | 0.013 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.037 | 0.027 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.026 | 0.016 | 0.026 | Complement factor 1r inhibitor | |||
| 0.037 | 0.028 | 0.037 | TRPM8 blocker | |||
| 0.017 | 0.007 | 0.017 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.027 | 0.017 | 0.027 | Calcium-sensing receptor agonist | |||
| 0.06 | 0.05 | 0.06 | CDC25B inhibitor | |||
| 0.022 | 0.012 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Cyclin E2 inhibitor | |||
| 0.031 | 0.022 | 0.031 | HCV NS5B polymerase inhibitor | |||
| 0.052 | 0.042 | 0.052 | Carbonic anhydrase I inhibitor | |||
| 0.019 | 0.009 | 0.019 | Telomerase stimulant | |||
| 0.048 | 0.038 | 0.048 | Cannabinoid CB2 receptor antagonist | |||
| 0.04 | 0.03 | 0.04 | CDK5/p25 inhibitor | |||
| 0.018 | 0.009 | 0.018 | NMDA receptor phencyclidine site antagonist | |||
| 0.035 | 0.025 | 0.038 | Opioid delta receptor agonist | 0.038 0.022 CID_154699930 | CID_154699930 | |
| 0.101 | 0.092 | 0.101 | Acetylcholine antagonist | |||
| 0.039 | 0.03 | 0.039 | Kainate receptor antagonist | |||
| 0.014 | 0.005 | 0.014 | Melatonin 2 antagonist | 0.012 0.009 CID_154699930 | ||
| 0.016 | 0.008 | 0.016 | Angiotensin AT1B receptor antagonist | |||
| 0.039 | 0.031 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.049 | 0.04 | 0.051 | 5 Hydroxytryptamine 4 antagonist | 0.051 0.036 CID_154699930 | CID_154699930 | |
| 0.042 | 0.034 | 0.042 | Purinergic P2Y antagonist | |||
| 0.019 | 0.011 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.027 | 0.019 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.031 | 0.024 | 0.031 | Dipeptidyl peptidase II inhibitor | |||
| 0.044 | 0.037 | 0.044 | CC chemokine 4 receptor antagonist | |||
| 0.102 | 0.095 | 0.102 | MAP kinase 12 inhibitor | |||
| 0.015 | 0.008 | 0.019 | Melatonin receptor 1A antagonist | 0.019 0.005 CID_154699930 | CID_154699930 | |
| 0.034 | 0.027 | 0.034 | Kainate receptor 2 antagonist | |||
| 0.034 | 0.028 | 0.034 | Nicotinic acid receptor agonist | |||
| 0.05 | 0.044 | 0.05 | Carbonic anhydrase II inhibitor | |||
| 0.094 | 0.088 | 0.137 | Interleukin 1b antagonist | 0.137 0.049 CID_154699930 | CID_154699930 | |
| 0.018 | 0.012 | 0.024 | Progesterone agonist | 0.024 0.009 CID_154699930 | CID_154699930 | |
| 0.02 | 0.014 | 0.02 | Retinoic acid beta receptor agonist | |||
| 0.034 | 0.028 | 0.034 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.038 | 0.032 | 0.083 | DNA-dependent protein kinase inhibitor | 0.083 0.009 CID_154699930 | CID_154699930 | |
| 0.06 | 0.054 | 0.06 | Histone deacetylase inhibitor | |||
| 0.054 | 0.048 | 0.054 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.044 | 0.039 | 0.044 | Benzodiazepine inverse agonist | |||
| 0.029 | 0.024 | 0.029 | Epoxide hydrolase 1 inhibitor | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.022 | 0.017 | 0.022 | ICAM 1 antagonist | |||
| 0.016 | 0.011 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.02 | 0.015 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.046 | 0.042 | 0.046 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.025 | 0.02 | 0.025 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.061 | 0.057 | 0.061 | Sirtuin 1 inhibitor | |||
| 0.051 | 0.047 | 0.051 | Glutamate (mGluR1) antagonist | |||
| 0.071 | 0.067 | 0.071 | Platelet growth factor antagonist | |||
| 0.007 | 0.004 | 0.007 | CC chemokine 6 receptor agonist | |||
| 0.066 | 0.063 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.017 | 0.014 | 0.017 | CXC chemokine 5 receptor antagonist | |||
| 0.043 | 0.039 | 0.043 | Glutamate (mGluR group I) agonist | |||
| 0.097 | 0.094 | 0.097 | Histone deacetylase class III inhibitor | |||
| 0.016 | 0.013 | 0.016 | G-protein-coupled receptor 120 agonist | |||
| 0.067 | 0.064 | 0.067 | Adenosine A3 receptor antagonist | |||
| 0.028 | 0.026 | 0.028 | DNA topoisomerase IV inhibitor | |||
| 0.049 | 0.047 | 0.049 | Pim-2 kinase inhibitor | |||
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.086 | 0.084 | 0.086 | Insulin receptor antagonist | |||
| 0.036 | 0.034 | 0.036 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.051 | 0.049 | 0.051 | MAP kinase kinase 9 inhibitor | |||
| 0.063 | 0.061 | 0.102 | 5 Hydroxytryptamine 1 antagonist | 0.102 0.036 CID_154699930 | CID_154699930 | |
| 0.037 | 0.035 | 0.037 | Leukotriene C4 antagonist | |||
| 0.012 | 0.01 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.021 | 0.019 | 0.024 | Dopamine autoreceptor agonist | 0.024 0.016 CID_154699930 | CID_154699930 | |
| 0.066 | 0.064 | 0.066 | Protein kinase B beta inhibitor | |||
| 0.062 | 0.06 | 0.062 | Cannabinoid receptor antagonist | |||
| 0.019 | 0.018 | 0.019 | Factor XIII inhibitor | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.02 | 0.018 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.011 | 0.01 | 0.011 | Retinoic acid beta receptor antagonist | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.012 | 0.011 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.099 | 0.1 | 0.125 | Cyclooxygenase 1 inhibitor | 0.125 0.075 CID_154699930 | CID_154699930 | |
| 0.051 | 0.054 | 0.052 | Acetylcholine M3 receptor antagonist | 0.052 0.051 CID_154699930 | CID_154699930 | |
| 0.064 | 0.067 | 0.097 | CDC25A inhibitor | 0.097 0.029 CID_154699930 | CID_154699930 | |
| 0.08 | 0.084 | 0.096 | Uric acid excretion stimulant | 0.096 0.057 CID_154699930 | CID_154699930 | |
| 0.05 | 0.055 | 0.087 | Dopamine D3 antagonist | 0.087 0.029 CID_154699930 | CID_154699930 | |
| 0.053 | 0.061 | 0.084 | 5 Hydroxytryptamine 1A antagonist | 0.084 0.038 CID_154699930 | CID_154699930 | |
| 0.027 | 0.036 | 0.062 | Melatonin 1 agonist | 0.062 0.006 CID_154699930 | CID_154699930 | |
| 0.039 | 0.053 | 0.048 | Aldose reductase inhibitor | 0.048 0.04 CID_154699930 | CID_154699930 | |
| 0.041 | 0.056 | 0.061 | Beta tubulin antagonist | 0.061 0.039 CID_154699930 | CID_154699930 | |
| 0.052 | 0.072 | 0.097 | Dopamine antagonist | 0.097 0.04 CID_154699930 | CID_154699930 | |
| 0.023 | 0.043 | 0.032 | Melatonin 2 agonist | 0.032 0.025 CID_154699930 | CID_154699930 | |
| 0.139 | 0.161 | 0.283 | Free radical scavenger | 0.283 0.056 CID_154699930 | CID_154699930 | |
| 0.198 | 0.223 | 0.283 | Alpha-glucosidase inhibitor | 0.283 0.169 CID_154699930 | CID_154699930 | |
| 0.042 | 0.068 | 0.084 | Dopamine D2 antagonist | 0.084 0.038 CID_154699930 | CID_154699930 | |
| 0.04 | 0.067 | 0.097 | HIV-1 integrase (Strand Transfer) inhibitor | 0.097 0.024 CID_154699930 | CID_154699930 | |
| 0.06 | 0.087 | 0.089 | Phosphodiesterase IV inhibitor | 0.089 0.054 CID_154699930 | CID_154699930 | |
| 0.195 | 0.228 | 0.287 | DNA polymerase beta inhibitor | 0.287 0.172 CID_154699930 | CID_154699930 | |
| 0.141 | 0.177 | 0.298 | Antioxidant | 0.298 0.062 CID_154699930 | CID_154699930 | |
| 0.022 | 0.06 | 0.066 | 5 Hydroxytryptamine 2C agonist | 0.066 0.017 CID_154699930 | CID_154699930 | |
| 0.04 | 0.081 | 0.083 | Dopamine agonist | 0.083 0.035 CID_154699930 | CID_154699930 | |
| 0.058 | 0.101 | 0.101 | Alpha adrenoreceptor antagonist | 0.101 0.056 CID_154699930 | CID_154699930 | |
| 0.034 | 0.079 | 0.078 | 5 Hydroxytryptamine uptake inhibitor | 0.078 0.034 CID_154699930 | CID_154699930 | |
| 0.19 | 0.236 | 0.264 | DNA directed DNA polymerase inhibitor | 0.264 0.183 CID_154699930 | CID_154699930 | |
| 0.064 | 0.112 | 0.109 | Butyrylcholinesterase inhibitor | 0.109 0.054 CID_154699930 | CID_154699930 | |
| 0.041 | 0.093 | 0.065 | Alpha 1 adrenoreceptor antagonist | 0.065 0.063 CID_154699930 | CID_154699930 | |
| 0.083 | 0.135 | 0.161 | Acetylcholinesterase inhibitor | 0.161 0.049 CID_154699930 | CID_154699930 | |
| 0.098 | 0.157 | 0.411 | Sigma receptor agonist | 0.411 0.02 CID_154699930 | CID_154699930 | |
| 0.159 | 0.225 | 0.255 | Angiogenesis inhibitor | 0.255 0.119 CID_154699930 | CID_154699930 | |
| 0.093 | 0.169 | 0.169 | Amyloid beta aggregation inhibitor | 0.169 0.095 CID_154699930 | CID_154699930 | |
| 0.035 | 0.114 | 0.087 | HIV-1 integrase (3'-Processing) inhibitor | 0.087 0.031 CID_154699930 | CID_154699930 | |
| 0.097 | 0.21 | 0.292 | P-glycoprotein inhibitor | 0.292 0.03 CID_154699930 | CID_154699930 | |
| 0.088 | 0.213 | 0.217 | Nitric oxide antagonist | 0.217 0.062 CID_154699930 | CID_154699930 | |
| 0.047 | 0.19 | 0.268 | Breast cancer-resistant protein inhibitor | 0.268 0.008 CID_154699930 | CID_154699930 | |
| 0.07 | 0.214 | 0.124 | Cholinergic | 0.124 0.103 CID_154699930 | CID_154699930 | |
| 0.087 | 0.275 | 0.264 | Vasodilator | 0.264 0.062 CID_154699930 | CID_154699930 | |
| 0.029 | 0.238 | 0.12 | M18 aspartyl aminopeptidase inhibitor | 0.12 0.07 CID_154699930 | CID_154699930 | |
| 0.013 | 0.223 | 0.441 | 5 Hydroxytryptamine agonist | 0.441 0.005 CID_154699930 | CID_154699930 | |
| 0.008 | 0.221 | 0.067 | 5 Hydroxytryptamine 1 agonist | 0.067 0.029 CID_154699930 | CID_154699930 | |
| 0.052 | 0.273 | 0.163 | Interleukin 1 antagonist | 0.163 0.05 CID_154699930 | CID_154699930 | |
| 0.006 | 0.234 | 0.049 | 5 Hydroxytryptamine 1A agonist | 0.049 0.029 CID_154699930 | CID_154699930 | |
| 0.087 | 0.322 | 0.168 | Hypoglycemic | 0.168 0.15 CID_154699930 | CID_154699930 | |
| 0.018 | 0.254 | 0.076 | Phosphodiesterase V inhibitor | 0.076 0.045 CID_154699930 | CID_154699930 | |
| 0.018 | 0.273 | 0.069 | Phosphodiesterase 5A inhibitor | 0.069 0.051 CID_154699930 | CID_154699930 | |
| 0.068 | 0.331 | 0.232 | Tumour necrosis factor alpha release inhibitor | 0.232 0.084 CID_154699930 | CID_154699930 | |
| 0.021 | 0.337 | 0.083 | Antiadrenergic | 0.083 0.068 CID_154699930 | CID_154699930 | |
| 0.02 | 0.345 | 0.079 | Adrenaline antagonist | 0.079 0.069 CID_154699930 | CID_154699930 | |
| 0.014 | 0.379 | 0.114 | MAP3K7 inhibitor | 0.114 0.016 CID_154699930 | CID_154699930 | |
| 0.052 | 0.423 | 0.289 | Hepatoprotectant | 0.289 0.033 CID_154699930 | CID_154699930 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |